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Abstract
Agent No. 547 (1,3-bis[x-(diethyl-ortho-nitrobenzylammonio)-pentyl]-6-methyluracil dibromide),
a  newly synthesized inhibitor  of  mammalian-specific  acetyltcholinesterase (EC 3.1.1.7)  was
investigated for genotoxicity using the DNA-repair test, Ames test and in vivo micronucleus test
with mouse peripheral blood erythrocytes. Agent No. 547 did not cause significant changes in
growth of repair-deficient Escherichia coli tester strains. The compound was non-mutagenic in
Salmonella typhimurium strains TA98 and TA100 with and without rat microsomal activation
mixture. However, we observed a marked increase in number of His+ revertants for both tester
strains in preincubation assays. The results obtained in the micronucleus test indicate that
agent No. 547 possesses significant clastogenic activity. At the high dose tested (0.5 mg/kg),
the compound induced a seven-fold increase in the number of micronuclei over the spontaneous
background 48 h after treatment. The results suggest that further work should be promoted to
identify the metabolic pathways involved in genotoxicity of agent No. 547 in mammalian cells
and to evaluate the real risk of its exposure.
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